ArticleJournal of medicinal chemistry2025

MD-4251: A First-in-Class Oral MDM2 Degrader Inducing Complete Tumor Regression with Single-Dose Administration.

Ranjan Kumar Acharyya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.